Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001424304 | SCV001626900 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2025-01-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001563313 | SCV001786231 | likely benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge |
Breakthrough Genomics, |
RCV001563313 | SCV005209544 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004734183 | SCV005345717 | likely benign | CACNA1A-related disorder | 2024-04-02 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |